Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Illumina (ILMN) stocks in Canada

Learn how to easily invest in Illumina stocks.

Illumina is a diagnostics & research business based in the US. Illumina stocks (ILMN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $239.81 – an increase of 2.68% over the previous week. Illumina employs 9,800 staff and has a trailing 12-month revenue of around $4.5 billion.

How to buy stocks in Illumina

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ILMN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Illumina stock price (NASDAQ:ILMN)

Use our graph to track the performance of ILMN stocks over time.

Illumina shares at a glance

Information last updated 2022-05-15.
Latest market close$239.81
52-week range$208.35 - $526.00
50-day moving average $319.33
200-day moving average $382.21
Wall St. target price$371.38
PE ratio 46.3413
Dividend yield $0 (0%)
Earnings per share (TTM) $5.04

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get $500 in commission free trades when you fund your account with a minimum of $10,000. Conditions apply. Ends August 31st, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Illumina stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Illumina price performance over time

Historical closes compared with the close of $239.81 from 2022-05-18

1 week (2022-05-10) 9.17%
1 month (2022-04-19) -29.94%
3 months (2022-02-18) -23.13%
6 months (2021-11-19) -36.78%
1 year (2021-05-20) -39.52%
2 years (2020-05-20) -32.96%
3 years (2019-05-20) 300.59
5 years (2017-05-19) 35.48%

Is Illumina under- or over-valued?

Valuing Illumina stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Illumina's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Illumina's P/E ratio

Illumina's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 46x. In other words, Illumina shares trade at around 46x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Illumina's PEG ratio

Illumina's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8598. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Illumina's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Illumina's EBITDA

Illumina's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $903 million.

The EBITDA is a measure of a Illumina's overall financial performance and is widely used to measure a its profitability.

Illumina financials

Revenue TTM $4.5 billion
Operating margin TTM 14.41%
Gross profit TTM $3.2 billion
Return on assets TTM 3.57%
Return on equity TTM 9.87%
Profit margin 16.84%
Book value $68.41
Market capitalisation $36.7 billion

TTM: trailing 12 months

Illumina's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Illumina.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Illumina's total ESG risk score

Total ESG risk: 9.18

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Illumina's overall score of 9.18 (as at 01/01/2019) is excellent – landing it in it in the 2nd percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Illumina is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Illumina's environmental score

Environmental score: 2.22/100

Illumina's environmental score of 2.22 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Illumina's social score

Social score: 2.6/100

Illumina's social score of 2.6 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Illumina's governance score

Governance score: 5.36/100

Illumina's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Illumina is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Illumina's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Illumina scored a 1 out of 5 for controversy – the highest score possible, reflecting that Illumina has managed to keep its nose clean.

Illumina share dividends

We're not expecting Illumina to pay a dividend over the next 12 months.

Have Illumina's shares ever split?

Illumina's shares were split on a 2:1 basis on 23 September 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Illumina shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Illumina shares which in turn could have impacted Illumina's share price.

Illumina share price volatility

Over the last 12 months, Illumina's shares have ranged in value from as little as $208.35 up to $526. A popular way to gauge a stock's volatility is its "beta".

ILMN.US volatility(beta: 0.93)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Illumina's is 0.9309. This would suggest that Illumina's shares are less volatile than average (for this exchange).

Illumina overview

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site